August 15, 2025 Release Highlights Copied
Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS), Enhancing Oncology Model (EOM), and Advance Care Planning. These updates will be available Monday, Aug. 18, 2025.
MIPS Promoting Interoperability Dashboard
For the measures listed below, clicking the information (i) icon will now open a new page that includes a description of the measure, how the measure is calculated, and a summary of changes based on the 2025 MIPS specifications:
- e-Prescribing
- Provide Patients Electronic Access to Their Health Information
- Query of PDMP
- Support Electronic Referral Loops by Receiving and Reconciling
- Support Electronic Referral Loops by Sending Health Information
Access the full Ontada Quality and Promoting Interoperability Help Menu at https://iknowmed.help.ontada.com/kb/en/2025-qpp-guide-312346.
EOM Performance Measures Dashboard
For the measures listed below, clicking the Information (i) icon will now open a new page that includes a description of the measure, how the measure is calculated, and a summary of changes based on the 2025 EOM specifications:
- EOM 4: Pain Assessment and Management Set
- EOM 4a: Pain Intensity Quantified
- EOM 4b: 144 Pain Care Plan
- EOM 5: Depression Screening
Access the full Ontada EOM Help Menu at https://iknowmed.help.ontada.com/kb/en/eom-guide-306886.
Advance Care Planning Dashboards
You can view the final data from Q1 2025 using the Time Period drop-down on the Advance Care Planning Performance and Advance Care Planning Activities dashboards.
Status of Dashboard Updates for 2025
CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. Ontada will continue to notify practices once measures have been updated based on the current 2025 requirements.
| Measure | Description |
|---|---|
| MIPS Quality Measures Dashboard | |
| MIPS #001 | Diabetes Hemoglobin A1c (HbA1cc) Poor Control (>9%) (Inverse Measure) |
| MIPS #047 | Advance Care Plan |
| MIPS #130 | Current Medications Documentation |
| MIPS #134 eCQM |
Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #134 CQM/Registry |
Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #143 | Pain Intensity Quantified |
| MIPS #144 | Pain Care Plan |
| MIPS #226 | Tobacco Screening and Cessation |
| MIPS #236 | Controlling High Blood Pressure |
| MIPS #238 | Use of High-Risk Medications in Older Adults (Inverse Measure) |
| MIPS #374 | Closing the Referral Loop |
| MIPS #450 | Appropriate Treatment for Patients with Stage I (T1c) III Her2 Positive Breast Cancer |
| MIPS #451 | RAS (KRAS & NRAS) Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-EGFR Monoclonal Antibody Therapy |
| MIPS #453 | Proportion Receiving Chemotherapy in the Last 14 Days of Life (Inverse Measure) |
| MIPS #457 | Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days |
| MIPS #462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
| MIPS #487 | Screening for Social Drivers of Health |
| PIMSH #1 | Advance Care Planning in Metastatic Disease |
| PIMSH #4 | Patient-Reported Pain Improvement |
| PIMSH #9 | Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure) |
| PIMSH #10 | Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs |
| PIMSH #13 | Proportion of Stage IV nsNSCLC Patients Tested for Actionable Biomarkers and Received Mutation-Targeted Therapy |
| PIMSH #15 | Antiemetic Therapy for Low-and Minimal-Emetic-Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure) |
| PIMSH #16 | Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center |
| PIMSH #17 | Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (Inverse Measure) |
| PIMSH #18 | Resolution or Improvement of a Health-Related Social Need |
| EOM Performance Measures Dashboard | |
| EOM-4A | Pain Intensity Quantified |
| EOM-4B | Pain Care Plan |
| EOM-5 | Preventive Care Screening: Screening for Depression and Follow Up Plan |